Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Cell Immunol ; 287(1): 46-52, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24380839

RESUMEN

The LAIR-1 receptor is expressed on a majority of mononuclear leukocytes. It is used as a biomarker when testing synovial fluid for evidence of rheumatoid arthritis (RA). The primary objective of this study was to measure T cell- and monocyte/macrophage-specific LAIR-1 expression in RA patients and compare this to LAIR-1 expression in osteoarthritis (OA) patients and healthy individuals. LAIR-1 expression was significantly decreased in circulating CD4(+) T cells in RA patients compared to both OA patients and healthy individuals. In contrast, LAIR-1 is high in CD14(+) monocytes and local CD68(+) macrophages in synovial tissues from RA patients. Upon stimulation with TNF-α, LAIR-1 expression decreased in T-helper (Th)1 and Th2 CD4(+) T cells from healthy donors. These results indicate that LAIR-1 may exert different functions on T cells and monocytes/macrophages and suggest that LAIR-1 may be a novel therapeutic target for the treatment of RA.


Asunto(s)
Artritis Reumatoide/inmunología , Biomarcadores/metabolismo , Linfocitos T CD4-Positivos/inmunología , Macrófagos/inmunología , Osteoartritis/inmunología , Receptores Inmunológicos/metabolismo , Adulto , Anciano , Células Cultivadas , Femenino , Regulación de la Expresión Génica , Humanos , Masculino , Persona de Mediana Edad , Especificidad de Órganos , Receptores Inmunológicos/inmunología , Membrana Sinovial/inmunología , Balance Th1 - Th2
2.
Int J Immunogenet ; 36(4): 227-9, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19473214

RESUMEN

We report a significantly higher occurrence of HLA-DRB1*09 (51% vs. 23%, P = 0.002, OR = 3.57) and HLA-B*46-DRB1*09 (26% vs. 8%, P = 0.018, OR = 3.76) in patients with haemorrhagic fever with renal syndrome (HFRS) compared to the control group, suggesting Hantaan virus-induced HFRS is associated with a genetic predisposition in the Chinese Han population.


Asunto(s)
Predisposición Genética a la Enfermedad , Antígenos HLA-A/genética , Antígenos HLA-DR/genética , Virus Hantaan , Fiebre Hemorrágica con Síndrome Renal/genética , Fiebre Hemorrágica con Síndrome Renal/inmunología , Alelos , Pueblo Asiatico/genética , China/epidemiología , Frecuencia de los Genes , Genotipo , Antígenos HLA-B/genética , Cadenas HLA-DRB1 , Haplotipos/genética , Fiebre Hemorrágica con Síndrome Renal/epidemiología , Humanos , Modelos Logísticos , Estudios Retrospectivos
3.
Neuroscience ; 158(2): 766-75, 2009 Jan 23.
Artículo en Inglés | MEDLINE | ID: mdl-18793698

RESUMEN

CD226, a member of cell adhesion molecules, has been widely studied in the immune system; however, its expression in the CNS remains unknown. In our present study, we detected CD226 mRNA and protein in the mouse hippocampus and cerebellum by RT-PCR and Western blotting, respectively. Immunohistochemical studies found that CD226 is primarily located in the hilus of the dentate gyrus and stratum lucidum aligned along the pyramidal cells in the hippocampal CA3 area, the interspaces of granular cells and the somata of the Purkinje cells in the cerebellar cortex during adulthood. Double-staining results revealed that CD226 co-localized well with synaptic marker proteins including synaptophysin, syntaxin and PSD-95. During postnatal development, CD226 could not be detected at its adult locations until postnatal day 12; however, it was temporally expressed in the somata of neighboring or distant nuclei associated with its adult location. These results showed the diverse localization of CD226 in the mouse hippocampus and cerebellum for the first time and suggested its potential role in the CNS.


Asunto(s)
Antígenos de Diferenciación de Linfocitos T/metabolismo , Cerebelo/crecimiento & desarrollo , Cerebelo/metabolismo , Hipocampo/crecimiento & desarrollo , Hipocampo/metabolismo , Animales , Animales Recién Nacidos , Antígenos de Diferenciación de Linfocitos T/genética , Homólogo 4 de la Proteína Discs Large , Guanilato-Quinasas , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Masculino , Proteínas de la Membrana/metabolismo , Ratones , Ratones Endogámicos BALB C , Fosfopiruvato Hidratasa/metabolismo , Proteínas Qa-SNARE/metabolismo , Sinaptofisina/metabolismo
4.
J Viral Hepat ; 14(7): 512-9, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17576393

RESUMEN

Hepatitis B virus surface antigen (HBsAg), a specific antigen on the membrane of hepatitis B virus (HBV)-infected cells, provides a perfect target for therapeutic drugs. In order to mediate successful targeted delivery of these therapies, it is essential to have antibodies that recognize HBsAg with high specificity and affinity. In this report, we constructed a natural immune antigen binding fragments (Fab) antibody phage display library against HBsAg and after three rounds of panning, five Fab fragments with significant HBsAg binding ability were selected and analysed. DNA sequencing revealed that all the light chains had the same sequence, while all the Fd genes exhibited different sequences. For further application, all of the Fab antibodies were reconstructed into single chain antibodies (scFvs) and expressed in Escherichia coli BL21 cells. Indirect enzyme-linked immunosorbent assay analysis demonstrated that all five scFvs maintained a high affinity for HBsAg and could bind HBsAg on the membrane of HBV-infected cells. Indirect fluorescent staining analysis revealed that one of the scFvs (scFv15) could be internalized into HBsAg-positive HepG2.2.15 cells through clathrin-mediated endocytosis pathway. The internalizing scFv15 antibody would have great potential for the targeted delivery of therapeutics to HBV-infected cells.


Asunto(s)
Especificidad de Anticuerpos , Anticuerpos contra la Hepatitis B/metabolismo , Antígenos de Superficie de la Hepatitis B/metabolismo , Virus de la Hepatitis B/inmunología , Región Variable de Inmunoglobulina/metabolismo , Biblioteca de Péptidos , Afinidad de Anticuerpos , Linfocitos B , Línea Celular , Hepatitis B/prevención & control , Anticuerpos contra la Hepatitis B/química , Anticuerpos contra la Hepatitis B/genética , Anticuerpos contra la Hepatitis B/inmunología , Vacunas contra Hepatitis B/administración & dosificación , Vacunas contra Hepatitis B/inmunología , Virus de la Hepatitis B/metabolismo , Humanos , Región Variable de Inmunoglobulina/química , Región Variable de Inmunoglobulina/genética , Región Variable de Inmunoglobulina/inmunología , Datos de Secuencia Molecular
5.
Gene Ther ; 13(4): 313-20, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16267568

RESUMEN

Apoptosis-inducing factor (AIF) represents a caspase-independent apoptotic pathway in the cell, and a mitochondrial localization sequence-truncated AIF (AIFDelta1-120) can be relocated from the cytoplasm to the nucleus and exhibit a constitutive proapoptotic activity. Here, we generated a chimeric immuno-AIF protein, which comprised an HER2 antibody, a Pseudomonas exotoxin translocation domain and AIFDelta1-120. Human Jurkat cells transfected with the immuno-AIF gene could express and secrete the chimeric protein, which selectively recognized HER2-overexpressing tumor cells and was endocytosed. Subsequent cleavage of truncated AIF from immuno-AIF and its release from the internalized vesicles resulted in apoptosis of tumor cells. Intramuscular injection of the immuno-AIF gene caused significant suppression of tumors and substantially prolonged mice survival in an HER2-overexpressing xenograft tumor model. Our study demonstrates the feasibility of the immuno-AIF gene as a novel approach to treating cancers that overexpress HER2.


Asunto(s)
Factor Inductor de la Apoptosis/genética , Regulación Neoplásica de la Expresión Génica , Genes erbB-2 , Terapia Genética/métodos , Neoplasias/terapia , ADP Ribosa Transferasas/genética , Anticuerpos/genética , Apoptosis/genética , Toxinas Bacterianas/genética , Línea Celular , Línea Celular Tumoral , Exotoxinas/genética , Femenino , Humanos , Células Jurkat , Neoplasias/genética , Receptor ErbB-2/inmunología , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Transfección/métodos , Factores de Virulencia/genética , Exotoxina A de Pseudomonas aeruginosa
6.
Transplant Proc ; 36(5): 1340-3, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15251327

RESUMEN

Renal transplantation is the best treatment of some end-stage renal diseases. Unfortunately, not every transplant is successful due to the rejection or dysfunction of the transplanted kidney. Many cytokines participate in rejection by inducing inflammation or apoptosis. In this study, the expressions of TRAIL, DR4, and DR5 in rejected renal tissue and of serum soluble TRAIL (sTRAIL) in patients with kidney rejection were investigated by immunohistochemical staining and sandwich enzyme-linked immunosorbent assay, respectively. The results showed that the expression of TRAIL, DR4 and DR5, and serum sTRAIL levels were markedly upregulated among renal transplant patients. Since both membrane and soluble forms of TRAIL can induce apoptosis of DR4/DR5-expressing cells via recruiting FADD and caspase 8, elevated TRAIL and its receptors may participate in renal graft rejection.


Asunto(s)
Antígeno HLA-DR4/análisis , Antígeno HLA-DR5/análisis , Trasplante de Riñón/inmunología , Glicoproteínas de Membrana/análisis , Factor de Necrosis Tumoral alfa/análisis , Apoptosis , Proteínas Reguladoras de la Apoptosis , Ensayo de Inmunoadsorción Enzimática , Antígeno HLA-DR4/sangre , Antígeno HLA-DR4/genética , Antígeno HLA-DR5/sangre , Antígeno HLA-DR5/genética , Humanos , Trasplante de Riñón/patología , Glicoproteínas de Membrana/sangre , Glicoproteínas de Membrana/genética , Valores de Referencia , Ligando Inductor de Apoptosis Relacionado con TNF , Factor de Necrosis Tumoral alfa/genética
7.
World J Gastroenterol ; 7(4): 583-6, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11819836

RESUMEN

AIM: To identify hepatitis C virus(HCV) core protein epitopes recognized by HLA-A2 restricted cytotoxic T lymphocyte (CTL). METHODS: Utilizing the method of computer prediction followed by a 4h(51)Cr release assay confirmation. RESULTS: The results showed that peripheral blood mononuclear cells (PBMC) obtained from two HLA-A2 positive donors who were infected with HCV could lyse autologous target cells labeled with peptide "ALAHGVRAL (core 150-158)". The rates of specific lysis of the cells from the two donors were 37.5% and 15.8%, respectively. Blocking of the CTL response with anti-CD4 mAb caused no significant decrease of the specific lysis. But blocking of CTL response with anti-CD8 mAb could abolish the lysis. CONCLUSION: The peptide (core 150-158) is the candidate epitope recognized by HLAA2 restricted CTL.


Asunto(s)
Antígeno HLA-A2/genética , Hepatitis C/inmunología , Linfocitos T Citotóxicos/inmunología , Proteínas del Núcleo Viral/genética , Secuencia de Aminoácidos , Anticuerpos Antivirales/inmunología , Linfocitos B/citología , Línea Celular , Mapeo Epitopo , Antígeno HLA-A2/inmunología , Hepacivirus/inmunología , Humanos , Fragmentos de Péptidos/inmunología , Fragmentos de Péptidos/farmacología , Valor Predictivo de las Pruebas , Linfocitos T Citotóxicos/virología , Proteínas del Núcleo Viral/inmunología
8.
Sheng Li Xue Bao ; 53(4): 296-302, 2001 Aug.
Artículo en Chino | MEDLINE | ID: mdl-11930209

RESUMEN

In order to elucidate the intrinsic mechanism underlying proliferation and differentiation of megakaryocytes during ontogenesis, CD34(+) cells were isolated from human fetal liver (FL) with a high-gradient magnetic sorting system (MACS) and were incubated in liquid suspension with 50 and 100 ng/ml of thrombopoietin (TPO) and in MegaCult(Tm) -C semi-solid culture system with 0, 12.5, 25, 50, 100, and 200 ng/ml of TPO. The cell number, colony number of CFU-Mk, platelet-associated antigen phenotype, and DNA ploidy of CD41(+) cells were examined from d 0 to d 12 in culture. The expression patterns of cyclins B1, D1, and D3 were also analyzed by using immunoblot and flow cytometry. TPO stimulated proliferation of CD34(+) cells of FL from 1 x 10(5)/ml to 13.12 +/-4.06 10(5)/ml with 95% of CD41a(+) cells and 3% of CD34(+) cells after 12 d of culture. Most of the megakaryocytes (MKs) derived from FL were in 2 N ploidy class, and few in 4 N ploidy class, but no megakaryocytes ploidy class was higher than 4 N. The effect of TPO on the formation of CFU-Mk colonies from FL derived CD34(+) cells is shown in a dose-response curve. The expression of cyclin B1 increased progressively and the high level of cyclin B1 was maintained in FL CD34(+) cells induced by TPO during 12 d of culture. A high level of cyclin B1 appeared on FL derived MKs of G1 phase at d 12. The expression of cy-of cyclins D1 and D3 gradually increased in FL CD34(+) cells, which was induced by TPO during the initial 6-day incubation. Afterwards, the level of cyclins D1 and D3 decreased progressively, particularly in MKs which were in G2+M phases. These data suggest that (1) TPO induced proliferation and differentiation of FL derived CD34(+) cells through upregulation of cyclin B1 in G2+M phases and cyclins D1 and D3 in all phases of cell cycle, and (2) Continuing high level of cyclin B1 and decreases of cyclins D1 and cyclin D3 on MKs in G2+M phases may contribute to a retardation of MK endoreduplication.


Asunto(s)
Antígenos CD34/metabolismo , Ciclinas/metabolismo , Hígado/citología , Megacariocitos/citología , Trombopoyetina/farmacología , Diferenciación Celular , División Celular , Células Cultivadas , Feto , Células Madre Hematopoyéticas/citología , Humanos
9.
J Parasitol ; 86(4): 822-6, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10958464

RESUMEN

A set of oligonucleotide primers I and II was developed by analyzing the specificity of a cloned kinetoplast DNA (kDNA) fragment of Leishmania donovani and sequencing the fragment. Polymerase chain reaction (PCR) was conducted with the primers to amplify a minicircle kDNA fragment (297 bp) to detect L. donovani in the bone marrow (22 samples), whole blood (16 samples), and serum (17 samples) of 22 patients with visceral leishmaniasis. All of 22 patients were diagnosed by microscopic identification. Control samples of bone marrow, whole blood, and serum were obtained from patients with leukemia and from healthy volunteers. In addition, 12 dogs were infected with L. donovani promastigotes for the PCR test. The total number of patients positive by PCR testing was 95.5% (21/22), with 91.0% (20/22) from the bone marrow, 68.8% (11/16) from the blood, and 29.4% (5/17) from the sera. Similar results were obtained in infected dogs. No amplification products were seen in control samples from humans or dogs. Our results suggest that PCR may be useful in detecting kDNA in the bone marrow and blood of patients with visceral leishmaniasis.


Asunto(s)
Médula Ósea/parasitología , ADN de Cinetoplasto/química , Leishmania donovani/genética , Leishmaniasis Visceral/diagnóstico , Animales , Secuencia de Bases , Cartilla de ADN , ADN de Cinetoplasto/análisis , ADN de Cinetoplasto/sangre , ADN Recombinante , Perros , Humanos , Leishmania donovani/aislamiento & purificación , Datos de Secuencia Molecular , Plásmidos , Reacción en Cadena de la Polimerasa , Sensibilidad y Especificidad , Análisis de Secuencia de ADN , Especificidad de la Especie , Bazo/parasitología
10.
Hybridoma ; 19(6): 489-94, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11152401

RESUMEN

Recently the platelet and T-cell activation antigen 1 (PTA1) was assigned as CD226 at the 7th Conference and Workshop on Human Leukocyte Differentiation antigens (HLDA). PTA1 is mainly expressed on activated T cells, natural killer (NK) cells, platelets and stimulated endotheliocytes, and involved in the differentiation of cytotoxic T lymphocytes (CTL) and NK, as well as platelet activation and aggregation. We raised hybridomas secreting monoclonal antibodies (MAbs) to PTA1 by using the natural PTA1 as immunogen, which was purified from platelets via affinity chromatography. These MAbs, designated FMU1, FMU2, FMU3, FMU4, FMU5, FMU6 and FMU7, could recognize PTA1 cDNA transfected COS7 cells detected by flow cytometry (FCM), and also react with both natural PTA1 and PTA1/Ig fusion protein in indirect enzyme-linked immunoadsorbent assay (ELISA). The biosensor epitope mapping assay showed that the seven MAbs, together with previous PTA1-specific MAbs Leo A1 and New E1, could bind seven distinct epitopes of PTA1, respectively. The panel of MAbs might be new powerful tools to study the structure-function relationship of PTA1 molecule, and to search for the ligand of PTA1.


Asunto(s)
Anticuerpos Monoclonales/biosíntesis , Antígenos de Diferenciación de Linfocitos T/inmunología , Mapeo Epitopo , Animales , Anticuerpos Monoclonales/inmunología , Anticuerpos Monoclonales/aislamiento & purificación , Antígenos de Diferenciación de Linfocitos T/genética , Antígenos de Diferenciación de Linfocitos T/aislamiento & purificación , Plaquetas/inmunología , Células COS , Epítopos/análisis , Epítopos/inmunología , Humanos , Hibridomas , Inmunoensayo , Ratones , Linfocitos T/inmunología , Transfección
11.
Zhonghua Yu Fang Yi Xue Za Zhi ; 28(6): 333-6, 1994 Nov.
Artículo en Chino | MEDLINE | ID: mdl-7867449

RESUMEN

Swine, fed with fodder containing 8%-16% rape-seed meal, took 919.42-1416.02 mg of thioglucoside (glucosinolate) daily. After being fed with it for 120 consecutive days, swine's thyroid enlarged and their thyroid follicles and epithelial cells were prominently hyperplastic, lacking secretory granules and lysosome in thyroid cytoplasm, with microvilli condensed in apical cells, and a great number of vacuoles surrounding the colloid in the follicular cavity, with its secretory function vigorous and significantly increased T4 and ratio of T4 to T3, and showing hyperthyroidism. If iodine was supplied in the fodder and the antidotes were administered, the morphology and ultrastructure of the thyroid tissues in swine restored to normal, and their T4 and ratio of T4 to T3 tended to be normal, too.


Asunto(s)
Hipertiroidismo/inducido químicamente , Yodo/metabolismo , Tioglucósidos/toxicidad , Animales , Hipertiroidismo/prevención & control , Yodo/uso terapéutico , Porcinos , Tiroxina/sangre , Triyodotironina/sangre
12.
Neurosci Lett ; 132(2): 151-4, 1991 Nov 11.
Artículo en Inglés | MEDLINE | ID: mdl-1784415

RESUMEN

Interleukin-1 (IL-1) alpha was injected into the lateral ventricle of the rat. An antiserum against Fos oncoprotein was used to detect the activated neurons immunohistochemically. A large number of neurons in the parvocellular paraventricular nucleus of the hypothalamus, in an area corresponding to the location of the corticotropin-releasing factor (CRF)-containing neurons, were strongly Fos-like immunoreactive (LI). Double immunostaining for Fos and CRF revealed that many of the Fos-LI cells were CRF-LI. Furthermore, the CRF-like immunoreactivity was greatly enhanced in the rats injected with IL-1 alpha, indicating an increase in CRF synthesis.


Asunto(s)
Hormona Liberadora de Corticotropina/metabolismo , Interleucina-1/farmacología , Neuronas/fisiología , Núcleo Hipotalámico Paraventricular/metabolismo , Animales , Núcleo Celular/metabolismo , Femenino , Inmunohistoquímica , Neuronas/metabolismo , Proteínas Oncogénicas v-fos/metabolismo , Núcleo Hipotalámico Paraventricular/citología , Núcleo Hipotalámico Paraventricular/efectos de los fármacos , Ratas , Ratas Endogámicas
14.
Leuk Res ; 13(4): 297-305, 1989.
Artículo en Inglés | MEDLINE | ID: mdl-2523990

RESUMEN

This study examined the immunoregulatory role of recombinant interleukin 4 (IL-4), also known as B-cell stimulating factor 1, on the generation of cytotoxic effector cells from normal and leukaemic human blood mononuclear cells. When tested on cells from normal individuals, the addition of IL-4 to mixed lymphocyte cultures led to a dose-dependent proliferation of T-helper cells (CD3, 4 positive) with a concomitant decrease in phenotypic and functional cytotoxic T cells and natural killer (NK) cells. IL-4 also inhibited the interleukin-2 (IL-2)-induced generation of lymphokine-activated killer (LAK) activity when added at the beginning of mixed lymphocyte culture. When tested on mature leukaemic NK cells, IL-4 also inhibited the ability of IL-2 to induce LAK function using a short-term culture system. These results show that IL-4 acts on both normal and leukaemic cells and suggests that it acts at more than one level during the development of LAK function.


Asunto(s)
Citotoxicidad Inmunológica/efectos de los fármacos , Interleucina-2 , Interleucinas/farmacología , Células Asesinas Naturales/inmunología , Leucemia/inmunología , Activación de Linfocitos/efectos de los fármacos , Linfocitos/clasificación , Antígenos de Diferenciación/análisis , Inhibidores de Crecimiento/farmacología , Humanos , Interleucina-4 , Prueba de Cultivo Mixto de Linfocitos , Linfocitos/análisis , Linfocitos/efectos de los fármacos , Fenotipo , Linfocitos T Citotóxicos/inmunología , Factor de Necrosis Tumoral alfa/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA